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Abstract:
Background: In pediatric patients, chronic
myeloid leukemia (CML) accounts for 2 to 5%
of all the leukemias but has an incidence of
less than 1 case per 1,00,000 population
younger than 20 years of age per year. CML is
a clonal hematopoietic stem cell disorder. As
per WHO classification, CML is included
in Myelodysplastic/Myeloproliferative
disorder. Adult type - CML is extremely rare in
childhood.
Case history: We report one such a case of
Adult type of CML in an 11 year old male
patient with chief complaints of abdominal
distension since 1 month and cough with fever
since 4-5 days. The clinical differential
diagnosis was malaria, storage disorder or
tropical splenomegaly. Though biological
behaviour and prognosis are identical to that of
adult type, we are reporting this case because
of its extremely uncommon incidence.
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Introduction:
Chronic myeloid leukemia (CML) is uncom-
mon in childhood, accounting for only 2-5%
of all leukemias [1]. CML is a clonal
hematopoietic stem cell disorder. It has
incidence of less than 1 case per 1, 00,000
population younger than 20 years of age per
year [2, 3]. Two distinct forms have been
described, namely - the juvenile and adult type
[4, 5]. Philadelphia (Ph) chromosome is rarely
seen in children [4]. The Manchester Children
Tumor Registry has reported only 9 cases in
23 years [4, 6].
The most of our knowledge of CML has been
derived from studies in the developed
countries. We report one such rare case of adult
type - CML in an 11 year old patient due to its
unusual incidence.
Case Report:
Eleven year male child came to the pediatric
OPD in our hospital with chief complaints of
abdominal distension since 1 month and cough
with fever since 4-5 days. The patient was well
immunized as per schedule. There was no
history of consanguineous marriage of parents.
On examination, the patient was averagely built
and averagely nourished. Local examination
revealed hard and distended abdomen. Liver was
palpable 7 cms and huge splenomegaly was
noted of 20 cms. In systemic examination 
respiratory system revealed reduced air entry
on right side. The patient was admitted in
pediatric ward with differential diagnosis of
malaria, storage disorder or tropical
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splenomegaly.
Routine hemogram was carried out, which
revealed Hb  10.7 gm/dl with markedly elevated
Total leukocyte count of 2, 46,000/Cumm (246
× 109/ lit). A peripheral differential count
revealed shift of myeloid series up to
myeloblasts. Basophilia and eosinophilia was
noted. (Polymorphs + Band forms = 47%,
Metamyelocytes = 22%, Myelocyte = 10%,
Promyelocytes = 02%, Blasts = 01%,
Lymphocytes = 03%, Eosinophils = 07%,
Monocytes = 03%, Basophils = 05%) (Fig. 1,
2). Platelet count was increased with 8.85 lac/
Cumm (885 × 109/ lit). On peripheral smear
examination, the diagnosis of - Chronic
Myeloproliferative disorder suggestive of CML
(adult) type was given.
Bone marrow aspiration from sternal puncture
was carried out under all aseptic precautions,
which revealed hypercellular bone marrow with
myeloid predominance. Granulocyte series
showed all forms with increased
Fig 1: Photomicrograph of blood smear of pa-
tient showing marked leucocytosis with shift of
myeloid series (Giemsa stain, x 400).
metamyelocytes, band forms and myelocytes
(30%). Erythroid and lymphoid series were
suppressed. Megakaryocytes were increased in
number with micromegakaryocyte
predominance (Fig. 3, 4). With above
peripheral smear and bone marrow findings,
final diagnosis of adult type - CML was given.
Fig 2: Photomicrograph of blood smear of
patient showing basophilia, shift of myeloid
series and thrombocytosis (Giemsa stain, x1000).
Fig 3 : A bone marrow aspirate smear shows
hyper-cellular marrow with myeloid
predominance (Giemsa stain, x400).
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Cytogenetics [Philadelphia chromosome (Ph)]
was carried out, which was positive. Thus
diagnosis of Adult type of CML in 11 year old
male patient was confirmed and patient was on
chemotherapy with regular follow up.
Fig 4: Bone marrow aspirate shows marked
leucocytosis with shift of myeloid series with
micromegacaryocytes (Giemsa stain, x1000).
Discussion:
Amongst childhood leukemias, chronic
myeloid leukemia (CML), is a rare entity with
an annual incidence of one case per million
children [7]. Adult type of CML in children is
even rarer and is characterized by Philadelphia
chromosome [t (9:22)] positivity [8]. BCR 
ABL fusion gene is better prognostic variant in
children and accounts for 3-5% of childhood
leukemias [9].
The incidence of leukemia among children
younger than 15 years of age has shown a
moderate increase in the past 20 years, with the
trend primarily reflecting an increase in
incidence of Acute Lymphoblastic Leukemia
(ALL) during this period [10]. The two major
types of leukemia are ALL comprising nearly
three-forth and acute non-lymphoblastic
comprising 19%. [10] CML is very rare in this
age group.
CML in childhood presents as one of the two
clinically distinct syndromes  i.e. adult type
CML (ACML) which is Ph(1)  positive, and
juvenile CML, also known as Juvenile
Myelomonocytic Leukemia (JMML), which is
Ph(1)  negative. Diagnosis of such cases in
chronic phase can be done by hematological
investigations. CML occurring in children is
called as adult form CML, which has the same
clinical, morphologic and cytogenetic findings
as adult Ph positive CML.
We report one such a case of Adult type CML
on peripheral smear and bone marrow, in an 11
year old male patient.
Clinical features of ACML are similar to that
seen in CML occuring in adults as abdominal
distension. Hepatomegaly, splenomegaly and
generalized lymphadenopathy, anemia,
hyperleukocytosis has been observed in all
patients [4, 11]. The mean spleen size has been
13 cm and ranged from 8-22 cm as per Sinniah
et al [4].
Three phases have been described for CML.
Most patients are diagnosed in the first phase,
called the chronic phase with median duration
of 4-5 years. It can develop over time into the
second- accelerated phase (6-8 months) and
third- blast crisis phase (3-9 months) [5].
Accelerated and blast phase has worst
prognosis.
Sinniah D et al [4] have reported only 5 cases
of ACML out of 168 cases of leukemia in 13
Dhiraj B. Nikumbh  et al
115
JKIMSU, Vol. 1, No. 1, Jan-June 2012Journal of Krishna Institute of Medical Sciences University ã
year review. These cases have been treated with
busulphan and intrathecal methotrexate. Median
survival in all cases has been 30 months due to
acute leukemia transformation and septicemia.
They have stated that outlook for ACML remains
poor and treatment needs re-evaluation [4].
Mishra A et al [11] reported similar findings
for Ph positive CML in a child. Hehlmann R et
al in 1994 have given comparison of survival
of CML patients on busulphan and hydroxyurea
as 45 and 58 months respectively [4].
Allogenic bone marrow transplant is the most
successful therapy if a suitable HLA identical
donor is available for chronic phase CML [9].
For patients without a suitable donor, control
of the disease with chemotherapy (either
hydroxyurea/busulphan or alpha interferon) is
the best current alternative [5, 9, 12].
The same progress in the recent therapeutic
strategy for older adults with hematological
malignancies has also seen in younger adults.
One of the BCR-ABL tyrosine kinase
inhibitors, imatinib mesylate, is active for
elderly Ph-positive Leukemias including ALL
and CML [13].  Management of childhood CML
in chronic phase constitutes  Hydroxyurea,
interferon  alpha, imatinib, and stem cell
transplant as per Robert I [14].  Imatinib in
childhood CML, controls leukocyte count in
1-2 weeks but with variable non hematological
side effects. [14]
Our patient has presented with abdominal
distension and with hugely enlarged spleen i.e.
20 cms. Routine hemogram, Peripheral smear,
Bone marrow and Ph chromosome (BCR -
ABL) confirms the diagnosis of adult type
CML. Thus our case is fulfilling the
morphological and cytogenetic criteria required
for diagnosis of adult type CML. Patient is on
chemotherapy and on regular follow up.
This needs to be differentiated from the other
form of myeloproliferative disorder like
Juvenile Myelomonocytic Leukemia (JMML).
The term JMML is presently used to include
all leukemias of childhood, formerly classified
as Juvenile CML, Chronic Myelomonocytic
Leukemia and infantile Monosomy 7 syndrome
[5]. The disease mimics morphologically and
clinically most closely to CML, but has unique
biological characteristics. According to WHO
classification, JMML is one of the bridging
MDS/MPD category of myeloid neoplasms
[12]. JMML represents 18-36% of MDS in
children and about 2% of hematologic
malignant neoplasms. It occurs predominantly
in infants and young children less than 2 years
[1]. Hepatomegaly, lymphadenopathy, recurrent
infections and bleeding are the hallmarks of
JMML [1] with Leukocytosis with
monocytosis [> 5000 / ml i.e. (> 5 × 109/ L)].
Eosinophilia and basophilia are observed in
minority of the patients [1, 12]. JMML is Ph
chromosome negative with aggressive clinical
course. [1] These features have been absent in
our case.
We have diagnosed the adult CML on routine
peripheral smear examination and supported by
bone marrow and cytogenetic study. Though
biological behaviour and prognosis are
identical to that of adult type, we are reporting
this case because of its extremely uncommon
incidence in childhood.
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